Intraoperative low-dose S-ketamine reduces depressive symptoms in patients with Crohn's disease undergoing bowel resection: a randomized controlled trial

Z Zhang, WH Zhang, YX Lu, BX Lu, YB Wang… - Journal of clinical …, 2023 - mdpi.com
Background: Patients with Crohn's disease (CD) undergoing bowel resection often suffer
from depression and acute pain, which severely impairs their recovery. We aimed to …

Moxibustion ameliorates chronic inflammatory visceral pain via spinal circRNA-miRNA-mRNA networks: a central mechanism study

D Zhang, X Dong, X Li, Y Yang, H Li, Y Hong, G Yang… - Molecular Brain, 2024 - Springer
This study aimed to unveil the central mechanism of moxibustion treating chronic
inflammatory visceral pain (CIVP) from the angle of circRNA-miRNA-mRNA networks in the …

Medication use in a cohort of adults with chronic intestinal failure: A prospective cross‐sectional study

B Deleenheer, N Lauwers, I Spriet… - Nutrition in Clinical …, 2024 - Wiley Online Library
Background Oral drug therapy may be compromised in chronic intestinal failure (IF) because
of alterations in absorption and transit. Only scarce literature is available on which …

Risk of Attempted Suicide Among Patients With IBD: A Nationwide Longitudinal Follow-up Study

YP Wang, B Zhang, HE Wang, YM Bai… - Diseases of the Colon …, 2023 - journals.lww.com
BACKGROUND: Evidence suggests that IBD is related to an increased risk of depressive
disorder and suicide. OBJECTIVES: Whether IBD is an independent risk factor for suicide …

Opioid use and associated factors in 1676 patients with inflammatory bowel disease: a multicentre quality improvement project

S Baillie, JK Limdi, A Bassi, A Fraser, G Parkes… - Frontline …, 2023 - fg.bmj.com
Objective Despite its association with poorer outcomes, opioid use in inflammatory bowel
disease (IBD) is not well characterised in the UK. We aimed to examine the extent of opioid …

[HTML][HTML] Polysubstance use in inflammatory bowel disease is associated with increased risk of emergency department visits: a longitudinal study

K Bogale, I Zubrzycka, A Stuart, M Cesaire… - Annals of …, 2023 - ncbi.nlm.nih.gov
Background Polysubstance use (PSU), the simultaneous use of 2 or more substances of
abuse, is common in inflammatory bowel disease (IBD). Preliminary studies suggest it may …

Short-Term and Long-Term Opioid Use Is Associated With Poor Outcomes in Outpatients With Inflammatory Bowel Disease

L Telfer, S Dalessio, A Tinsley, M Coates - Gastro hep advances, 2023 - ghadvances.org
This study has several potential limitations. First, it was a retrospective analysis and is
subject to sampling error and recall bias. The use of International Classification of Diseases …

Legalization of cannabis does not reduce opioid prescribing in patients with inflammatory bowel disease: a difference-in-difference analysis

M Noureldin, T Van, S Cohen-Mekelburg… - Official journal of the …, 2022 - journals.lww.com
BACKGROUND: Cannabis may provide inflammatory bowel disease (IBD) patients with an
alternative to opioids for pain. METHODS: We conducted a difference-in-difference analysis …